Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Hamainza, Busiku ^a,b   Masaninga, Freddie ^d   Moonga, Hawela ^a   Mwenda, Mulenga ^a,c   Chanda Kapata, Pascalina ^a   Chalwe, Victor ^e   Chanda, Emmanuel ^a   Kamuliwo, Mulakwa ^a   Babaniyi, Olusegun Ayorinde ^d  

^a MINISTRY OF HEALTH   (Zambia)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c Akros Global Health   (Zambia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Maina Soko Military Hospital   (Zambia)

Author keywords

All ages; Antimalarial treatment; Artemether lumefantrine; Efficacy; Safety; Zambia

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PROTOZOAL DNA;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OBSERVATIONAL STUDY; PARASITE CLEARANCE; PARASITE DENSITY; PARASITE EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; STANDARDIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ZAMBIA; ADULT; AGED; DRUG COMBINATION; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MIDDLE AGED; NEWBORN; PLASMODIUM FALCIPARUM; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, PROTOZOAN; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT; ZAMBIA;

EID: 84964314361     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-430     Document Type: Article

References (21)

1. WHO: World Annual Report 2013. Geneva: World Health Organization; 2014.
2. WHO: World Malaria Report 2012. Geneva: World Health Organization; 2013.
3. Kamuliwo M, Chanda E, Haque U, Mwanza-Ingwe M, Sikaala C, Katebe-Sakala C, Mukonka V, Norris D, Smith D, Glass G, Moss W: The changing burden of malaria and association with vector control interventions in Zambia using district-level surveillance data, 2006-2011. Malar J 2013, 12:437.
4. Masaninga F, Chanda E, Chanda-Kapata P, Hamainza B, Masendu HT, Kamuliwo M, Kapelwa W, Chimumbwa J, Govere J, Otten M, Fall IS, Babaniyi O, Siziya S: Review of the malaria epidemiology and trends in Zambia. Asian Pac J Trop Biomed 2013, 3:89-94.
5. Sipilanyambe N, Simon J, Chanda P, Olumese P, Snow R, Hamer D: From chloroquine to artemether-lumefantrine: The process of drug policy change in Zambia. Malar J 2008, 7:25.
6. WHO: Guidelines for the Treatment of Malaria. Geneva: Roll Back Malaria, World Health Organization; 2006.
7. WHO: Guidelines for the Treatment of Malaria Second edn. Geneva: World Health Organization; 2010.
8. White N, Olliaro P: Strategies for the prevention of antimalarial drug resistance:rationale for combination chemotherapy for malaria. Parasit Today 1996, 12:399-401.
9. WHO: Emergency Response to Artemisinin Resistance in the Greater Mekong Sub-Regional Framework for Action 2013-2015. Geneva: World Health Oragnization; 2013.
10. WHO: Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization; 2009.
11. WHO: Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations. Geneva: World Health Oragnization; 2008.
12. Nambozi M, Van Geertruyden JP, Hachizovu S, Chaponda M, Mukwamataba D, Mulenga M, Ubben D, D'Alessandro U: Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J 2011, 10:50.
13. Ogutu B, Onyango K, Koskei N, Omondi E, Ongecha J, Otieno G, Obonyo C, Otieno L, Eyase F, Johnson J, Omollo R, Perkins DJ, Akhwale W, Juma E: Efficacy and safety of artemether-lumefantrine and dihydroartemisininpiperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study. Malar J 2014, 13:33.
14. Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck H-P, Marrast A-C, Cousin M, Rosenthal PJ: Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: A pooled analysis. Am J Trop Med Hyg 2011, 85:793-804.
15. Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, Badiaga S, Bertaux L, Delmont J, Morillon M, Silai R, Brouqui P, Parzy D: Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006. Am J Trop Med Hyg 2007, 77:431-437.
16. Bloland PB: Drug resistance in malaria. Geneva: World Health Organization; 2001.
17. Farnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, Lindegardh N: Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania. Malar J 2012, 11:176.
18. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet 2012, 379:1960-1966.
19. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
20. White N: The role of anti-malarial drugs in eliminating malaria. Malar J 2008, 7:S8.
21. WHO: Goals, Targets, Policies and Strategies for Malaria Control and Elimination. In World Malaria Report. Edited by González M. Geneva: World Health Organization; 2011:3-14.